Cortical correlates of behavioural change in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis

Eur Radiol Exp.

Piaggio N, Pardini M, Roccatagliata L, Scialò C, Cabona C, Bonzano L, Inglese M, Mancardi GL, Caponnetto C

doi: 10.1186/s41747-018-0045-6.

Amyotrophic Lateral Sclerosis

White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis

Neuropathol Appl Neurobiol.

Mollink J, Hiemstra M, Miller KL, Huszar IN, Jenkinson M, Raaphorst J, Wiesmann M, Ansorge O, Pallebage-Gamarallage M, van Cappellen van Walsum AM

doi: 10.1111/nan.12555.

Amyotrophic Lateral Sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet Neurol.

Writing Group, Edaravone (MCI-186) ALS 19 Study Group

doi: 10.1016/

Amyotrophic Lateral Sclerosis

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

JAMA Neurol.

Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A

doi: 10.1001/jamaneurol.

Amyotrophic Lateral Sclerosis

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Lancet Neurol.

Chia R, Chiò A, Traynor BJ

doi: 10.1016/

Amyotrophic Lateral Sclerosis

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

JAMA Neurol.

Zhao W, Beers DR, Hooten KG, Sieglaff DH, Zhang A, Kalyana-Sundaram S, Traini CM, Halsey WS, Hughes AM, Sathe GM, Livi GP, Fan GH, Appel SH

doi: 10.1001/

Amyotrophic Lateral Sclerosis

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Brain Behav.

Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, Tarnutzer AA

doi: 10.1002/brb3.630.

Amyotrophic Lateral SclerosisDementia

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

JAMA Neurol.

Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G

doi: 10.1001/jamaneurol.

Amyotrophic Lateral Sclerosis

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis

N Engl J Med.

Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A, Wymer J, Goutman SA, Heitzman D, Heiman-Patterson T, Jackson CE, Quinn C, Rothstein JD, Kasarskis EJ, Katz J, Jenkins L, Ladha S, Miller TM, Scelsa SN, Vu TH, Fournier CN, Glass JD, Johnson KM, Swenson A, Goyal NA, Pattee GL, Andres PL, Babu S, Chase M, Dagostino D, Dickson SP, Ellison N, Hall M, Hendrix K, Kittle G, McGovern M, Ostrow J, Pothier L, Randall R, Shefner JM, Sherman AV, Tustison E, Vigneswaran P, Walker J, Yu H, Chan J, Wittes J, Cohen J, Klee J, Leslie K, Tanzi RE, Gilbert W, Yeramian PD, Schoenfeld D, Cudkowicz ME

doi: 10.1056/NEJMoa

Related content

Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis

White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes

Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis